Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
I have needed a revenge trade on this turd ever since FDA rejection...maybe I can steal one here now.
All of the mindless speculation by people attempting to bash this stock, so they can buy more.... Child please!! If the company did file BK, it would actually possibly help them. This with the addition of a grant would allow them to restructure its debt while having proper funding to continue work on its strong drug candidates. Even the village idiot knows this is a buy! Bk doesn't mean it closes its doors. Look at Vermillion, received FDA approval while in BK at .05 and went to over $30 within a month. who are yall kidding trying to bash this stock like its dead? LMAO
Hey Kei
Yeah I guess I got lucky. If the volume picks up I'll get really happy.
Wow ADLS is cookin up something for Thursday.
That date now shows as 7/31/2011?
this stock is beaten down hard...so imo, it will be very interesting from here to say the least.
HERE FDA 7/11/2011 http://www.fdacal.com/fda-calendar
going up till tomrrow... news coming before earning call
0.015 ... up 22% :)
Timing for ADLS. Calculation for Dollar value covered
http://finance.yahoo.com/news/Advanced-Life-Sciences-to-prnews-892239666.html?x=0&.v=1
"Advanced Life Sciences further announced that it has reached an agreement with the Leaders Bank to amend the terms of its existing loan. As part of the agreement, Leaders Bank has waived the existing defaults and the Company has agreed to make an interest reserve payment of $186,000 by January 10, 2011. The due date for the $1.1 million principal payment that is currently due has been extended to April 1, 2011. This $1.1 million principal payment as well as an additional $1.0 million principal payment also due on April 1, 2011 can be further extended to January 1, 2012 if the Company pays $486,000 in additional interest reserve by April 1, 2011."
The news is out on Jan 3, 2011.
Volume on 12/30~01/03: 25M x avg. 0.028=$700,000
Volume on 01/04~03/04: 61M x avg. 0.02=$1,220,000
Volume on 03/07~03/09: 24M x avg. 0.014=$336,000
Total volume=110M
Total value= $2.26M
You can trust the company already covered the interest payment to extend to Jan 2012.
Any selling from this point is meaningless, just panic selling. Big buying opportunity for the rest of this week.
Do not miss!!!!!
ask is going up
Got back in. Couldn't believe how low it can go. (LOL) Picked up the shares in my ROTH IRA. If they don't BK and could actually get approval, it'll make my TTNP investment look like chump change.
FDA approvals by month http://www.fda.gov/newsevents/productsapprovals/default.htm
i like the 9am call as opposed to 4pm!lol
You meant to say worthless or a 100 to 500 bagger from these levels with FDA approval...I agree...but it is shameful to see a drug that without question works go by the wayside ...
My position on ADLS is that it will be worthless at some point or a 10 bagger. The risk/reward at current share price is worth playing the risk....
surf1944 Share Friday, February 11, 2011 1:42:11 PM
Re: surf1944 post# 2016 Post # of 2067
Bought back in & took the MOD position. ADLS will be much higher or near zero by the EOY.......
I agree...and I am waiting for that sub penny before I jump in...This drug works and this company failed due to outside forces...unless the Flavins were in on it too...But JMHO I doubt that was the case...This should have been approved 7/09 with this stock being easily close to 15 bucks per share now...
itsme, I think something good is cooking in the oven. Restanza is a great drug!!
To your point Surf, I would hope they would have some/any positive news to report, but to go more than 2 months without ANY update from the company is alarming. Only news out recently has been negative (dilution of stock, Leaders Bank claiming Advanced is in default, etc). If they don't have any positive news to share regarding a potential partner/acquirer, then the call will be very short. And it can't be the old "we're in discussions with several companies" type of jargon, because they need to be specific regarding their gameplan. Sub-penny will soon be upon us if there isn't any positive news next week.
This might happen to ADLS.
Biotech Merger and Acquisition Activity Looks Poised to Surge
7:35a ET March 17, 2011 (Market Wire)
M&A activity in the healthcare sector has been on the upswing in recent quarters. Going forward, larger healthcare firms are expected to continue searching for smaller, more speculative companies which are focusing on specific treatments and specialties in the medical sector. Recent reports suggest that not only is Big Pharma active in acquisitions, but also larger biotech firms are showing willingness to utilize their large resource pools to acquire smaller firms in a race to diversify and to build their reach. The Bedford Report examines the outlook for companies in the Biotechnology Industry and provides research reports on Cell Therapeutics, Inc. (NASDAQ: CTIC) and Repros Therapeutics, Inc. (NASDAQ: RPRX). Access to the full company reports can be found at:
www.bedfordreport.com/2011-03-CTIC
www.bedfordreport.com/2011-03-RPRX
A recent report from Deal Search Online claims that while the biotech sector saw a 40 percent drop in the number of M&A deals last year, the 115 deals in 2010 amounted to $57.5 billion, a 21 percent increase over 2009. The report suggests that the last decade saw an increase in the amount of biotech deals, led in part by pharmaceutical companies seeking new blockbuster drugs to fill the void left by drugs coming off patent.
The Bedford Report releases regular market updates on the Healthcare Sector so investors can stay ahead of the crowd and make the best investment decisions to maximize their returns. Take a few minutes to register with us free at www.bedfordreport.com and get exclusive access to our numerous analyst reports and industry newsletters.
Buying some ADLS today, why would the company telecast this company update if there wasn't going to be at least some upbeat news coming from ADLS....
Advanced Life Sciences to Host 2010 Fourth Quarter and Full-Year Financial Results Conference Call and Webcast
http://finance.yahoo.com/news/Advanced-Life-Sciences-to-prnews-481355057.html?x=0&.v=1
Thats just the next event calender date, not necessarily approval date.
I hope you are right. I believe in Restanza. Our national security needs this drug. Plus, I am very hopeful that this stock will at the end of the day bring us big rewards. I must admit, I cannot find a July 31, 2011 for FDA approval for Restanza. However, Restanza is a post Phase III drug and I think it may be found on a different calendar. I am with you!! I am long on ADLS.
next event schedule is 7/31/2011 if restanza gets approval its easily a billion dollar drug....based on o/s shares this is a $4 dollar stock based on 1x sales...if july is the date then we have plenty of time to load up at depressed prices...i would suspect that if things are going well and funding is raised we should start seeing some share price increase over the next 30 - 45 days prior to announcement.
scroll down the page and you will see the next event as 7/31/2011
Wow! Awesome news there. Way under-valued at these levels for sure.
SELLING rest of my shares before close.
ADLS stock charts look like stock is top heavy think this stock may start a downtrend in price i sold my position in stock this morrning.
Not sure if anyone seen this news from 11-2-10 I know its old but I couldn't find it posted.
http://ir.advancedlifesciences.com/phoenix.zhtml?c=190126&p=irol-newsArticle&ID=1490294&highlight=
Even after looking at the article -
It still seems a bit strongly alarmist to actually suggest
"conspire to kill" don'tcha think ?
Regardless this one (as the chart below shows) has really taken a beating.
http://finance.yahoo.com/echarts?s=ADLS.OB+Interactive#chart5:symbol=adls.ob;range=2y;indicator=volume;charttype=line;crosshair=on;ohlcvalues=0;logscale=on;source=undefined
Guess I'll move just move on since no one has posted back any reasons for buying a few 'risk' shares and taking a speculative run at this one.
Thanks - see ya - and GLTA
corp and govt pals...this should have been a done deal already for a drug that actually works...no excuses here...this is not Genta...
Conspiracy on whose part ?
*** the company itself
*** short sellers
*** competitor drug companies
Who would conspire to kill ?
CONSPIACY to kill this stock(aka drug)...looks like it to me
Hello,
I am brand new here -
Looking at the chart - OUCH !!
http://finance.yahoo.com/echarts?s=ADLS.OB+Interactive#chart5:symbol=adls.ob;range=2y;indicator=volume;charttype=line;crosshair=on;ohlcvalues=0;logscale=on;source=undefined
I am curious as to what everyone's take is as to why this has tanked so drastically and secondly am curious as to what are the prospects for a turn-around sometime in 2011 ??
Thanks - Jim
BKstock, I think that is old information. I checked the ADLS web page and they say nothing about a submission to the FDA in 2011. Clearly, any submission to the FDA would be important and would be reported on the web page. Right now ADLS needs to get through this nasty liquidity crisis. I think she will make it. Heaven knows Restanza is a great drug that is needed for national security reasons. Let's hope Brother Flavin can pull the rabbit out the hat.
It may be "a bit out of date" but please explain why the government would still be using a drug that only works about half the time and makes alot of the people sick that take it?
Thank you shotei for the info. However, I think it is a bit out of date. But again, thank you.
today was last selling to cover April 1st interest payment
I found this on yahoo. This is very interesting to read. I will load up more this week.
http://messages.finance.yahoo.com/Stocks_%28A_to_Z%29/Stocks_A/threadview?m=tm&bn=95361&tid=15943&mid=15943&tof=1&frt=1
It's going to take a political change for ADLS to go up. Please read post 1967.
It would have been nice if ADLS has gone up even just a little today. Nevertheless, the fact that it did not go down any further is a good sign. It even came off its new low. The worst may be over. However, I believe as soon as this stock settles down, it should drift back up. This is a short term liquidity crisis. ADLS's Restanza is a great drug and our military needs it badly. I believe this stock will make pay dirt for anyone who has the patience to hang in there. My TP is .50 in 6 months. GLTA
huge buy 1.5M on 13
buying 50M between 0.0125-0.012
Followers
|
43
|
Posters
|
|
Posts (Today)
|
0
|
Posts (Total)
|
2187
|
Created
|
04/20/07
|
Type
|
Free
|
Moderators |
Advanced Life Sciences Holdings, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of novel drugs in the areas of infectious disease, oncology, and respiratory disease. Its lead candidate includes Cethromycin, a novel once-a-day oral antibiotic under review by the FDA for the treatment of mild-to-moderate community acquired pneumonia. Cethromycin has also completed Phase III clinical trials for the treatment of respiratory tract infections. The company also has an exclusive worldwide license agreement with Abbott Laboratories for the development and commercialization of Cethromycin. Advanced Life Sciences? products under preclinical studies comprise ALS-357, a compound for the treatment of malignant melanoma; and ALS-886, a novel therapeutic for the treatment of inflammation-related tissue damage consisting of tissue damage associated with acute respiratory distress syndrome. Its products under preclinical studies also include product candidates derived from the company?s natural products-based chemistry platform. Advanced Life Sciences has collaborations and license agreements with Wyeth Pharmaceuticals, University of Illinois at Chicago, Baxter International, National Institute of Allergy and Infectious Diseases, and Defence Science and Technology Laboratory of the United Kingdom. The company was founded in 1999 and is headquartered in Woodridge, Illinois.
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |